Skip to content

Electrical Vestibular Nerve Stimulation (VeNS): A Follow-up Assessment of Long-term Usage

Electrical Vestibular Nerve Stimulation (VeNS): A Follow-up Safety Assessment of Long-Term Usage

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04783883
Enrollment
25
Registered
2021-03-05
Start date
2021-03-04
Completion date
2021-07-23
Last updated
2024-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Safety Issues

Keywords

Neuromodulation, Safety, Vestibular

Brief summary

A follow-up assessment study of the long-term safety of vestibular electrical stimulation as delivered by the Vestal DM Device.

Detailed description

A retrospective, open-label, follow-up study assessing the long-term safety and efficacy of vestibular electrical stimulation as delivered by the Vestal DM Device.

Interventions

DEVICEVestal DM

Battery powered non-invasive neurostimulation device (1.5mA)

Sponsors

R D Gardi Medical College, Ujjain
CollaboratorUNKNOWN
Neurovalens Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Vestal DM user (more than 6 months)

Exclusion criteria

* Vestal DM device user (less than 6 months)

Design outcomes

Primary

MeasureTime frameDescription
Assessment of hearing function as reported by formal audiometry testingBaselineFormal audiometry testing to be conducted using the AMTAS Flex Device

Secondary

MeasureTime frameDescription
Frequency of device related adverse eventsBaseline
Inspection of the skin behind the ears (mastoid area)BaselinePhotographic inspection of the skin behind the ears to confirm no skin irritation has been caused at the mastoid area where the electrode pads are placed
Otoscope examination of the inside of both ear canals and tympanic membranesBaselinePhotographs to be taken of both ear canals and both tympanic membranes using the Awelor Wireless Smart Otoscope (Model Number: T1).

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026